[Metabolism of plasma cholesterol and lipoproteins after total resection of the small intestine in patients with parenteral nutrition. Effects of the amount of phospholipids infused]
- PMID: 1478404
[Metabolism of plasma cholesterol and lipoproteins after total resection of the small intestine in patients with parenteral nutrition. Effects of the amount of phospholipids infused]
Abstract
The aim of this study was to investigate the plasma lipoprotein profile in 2 patients treated by parenteral nutrition for total small bowel resection over a 15 month period. According to the amount of infused phospholipids (6 g/d vs 3 g/d), infused during 4 non consecutive 6 month or 6 week periods, HDL-cholesterol, apolipoproteins AI and B plasma levels were 30 to 50% below normal values. During the higher phospholipid supply, cholesterolemia seemed normal; each phospholipid supply decrease was followed by a reduction of cholesterol, phospholipids and apolipoprotein B plasma levels of 40, 50 and 25%, respectively, while HDL-cholesterol and apolipoprotein AI plasma levels remained unchanged. Density gradient ultracentrifugation showed that plasma cholesterol changes were mainly due to cholesterol changes (as free cholesterol associated with phospholipids) located in the density range of 1.019-1.040, reflecting the presence of lipoprotein X-like particles, whose levels remained unchanged during each period. An apolipoprotein E, CII and CIII enrichment of plasma was observed and was more pronounced when patients received higher phospholipid infusion. These results show that, in patients without a small bowel, minor changes in phospholipids supply are responsible for serious alterations of the lipoprotein profile; formation of lipoprotein X-like particles could be favored by the low HDL levels in these patients.
Similar articles
-
Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate.J Clin Invest. 1979 Dec;64(6):1703-12. doi: 10.1172/JCI109633. J Clin Invest. 1979. PMID: 227938 Free PMC article.
-
Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.J Hum Hypertens. 1995 Jul;9(7):557-64. J Hum Hypertens. 1995. PMID: 7562885 Clinical Trial.
-
Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.Artery. 1982;10(4):266-85. Artery. 1982. PMID: 7181672
-
Beta blockers and their effects on lipoproteins, phospholipids, apoproteins A and B, in whole plasma and the different fractions.Int J Clin Pharmacol Ther Toxicol. 1982 Jun;20(6):259-64. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 6125482
-
Phospholipid-rich particles in commercial parenteral fat emulsions. An overview.Prog Lipid Res. 1996;35(2):133-53. doi: 10.1016/0163-7827(96)00001-x. Prog Lipid Res. 1996. PMID: 8944224 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical